EUCTR2006-001163-29-IT进行中（未招募）1 期
RESCUE CHEMIOTERAPY WITH MI Mitomicina e Isofosfamide in pancreatic adenocarcinoma with metastasis a phase II study. - ND
OSPEDALE S. RAFFAELE0 个研究点目标入组 34 人开始时间: 2006年3月14日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •pancreatic carcinoma diagnosis with metastasis, previous chemioterpy, age 50 and 76
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •cerebral metastasis, pregnancy, previous chemiotherapy with ifosfamide or mytomicin
研究者
相似试验
终止
2 期
Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic CancerPancreatic CancerNCT00967291IRCCS San Raffaele21
已完成
2 期
Chemotherapy consists of Adriamycin and Ifosfamide for the patients with high grade primary bone sarcoma except for Ewing sarcoma over 41, Phase II trialpatients with high grade primary bone sarcoma except for Ewing sarcoma over 41JPRN-UMIN000015982Japanese Musculoskeletal Oncology Group; JMOG35
已完成
不适用
Mitomycin, ifosfamide and cisplatin in non-small cell lung cancer (NSCLC): A randomised trial of chemotherapy plus radiotherapy versus radiotherapy aloneung (non-small cell) cancerLung (non-small cell)CancerISRCTN56319613Cancer Research UK (CRUK) (UK)
进行中（未招募）
不适用
Early salvage with high dose chemotherapy and stem cell transplantation in advanced stage Hodgkin?s lymphoma patients with positive positron emission tomography after two courses of ABVD (PET-2 positive) and comparison of radiotherapy versus no radiotherapy in PET-2 negative patients. - IIL HD 0801HODGKIN LYMPHOMAEUCTR2008-002684-14-ITIIL INTERGRUPPO ITALIANO LINFOMI ONLUS
已完成
2 期
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath TumorsNeurofibromatosis Type 1SarcomaNCT00304083Sarcoma Alliance for Research through Collaboration48